T-cell receptor specific for influenza A virus (H1N1) antigens

T-cell receptors (TCRs) specific for influenza A virus (H1N1) are specialized immune receptors that recognize viral peptides presented by Human Leukocyte Antigen (HLA) class I and II molecules [PubMed: 31160518]. These TCRs are essential for the cellular immune response, targeting both surface proteins like Hemagglutinin (HA) and Neuraminidase (NA), and highly conserved internal proteins such as Matrix protein 1 (M1) and Nucleoprotein (NP) [UniProt: P03485, P03466]. Upon binding to their cognate peptide-MHC complex, these receptors trigger T-cell activation, leading to the direct lysis of infected cells and the production of antiviral cytokines like Interferon-gamma [PubMed: 28922354]. In therapeutic development, these TCRs are being utilized in adoptive TCR-T cell therapies to provide potent, specific immunity against severe influenza infections [PubMed: 33452134]. They also serve as the primary targets for universal influenza vaccines, which aim to elicit broad-spectrum T-cell memory across different viral strains [NIH: NIAID Influenza Research]. Clinical challenges include the requirement for specific HLA matching and the risk of off-target reactivity against host tissues [PubMed: 25607440]. Furthermore, the high mutation rate of influenza viruses can lead to the loss of TCR recognition through antigenic drift.

Other names

H1N1-specific TCRInfluenza-specific T-cell receptorFlu-specific TCRAnti-influenza TCRT-cell receptors specific for peptides derived from H1N1 HA, NA, and internal influenza proteins presented on HLA class I/II

T-cell receptors (TCRs) recognize specific influenza-derived peptides presented by HLA molecules, leading to the formation of an immunological synapse and subsequent T-cell activation via the CD3 signaling complex, resulting in the release of cytotoxic molecules and pro-inflammatory cytokines [PubMed: 31160518].